Treatment with peginterferon versus interferon in Chinese patients with hepatitis B

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Hai-bo YuS Zhao

Abstract

Several new clinical trials to compare the efficiency of pegylated interferon (PEGIFN) treatment with IFN treatment in Chinese patients with hepatitis B were published in recent years. However, the numbers of patients included in these clinical trials are too small to draw a clear conclusion whether PEGIFN is more effective than INF in Chinese patients. Therefore, a new meta-analysis was needed to be performed to compare PEGIFN with IFN in the treatment of Chinese hepatitis B patients. A search of MEDLINE, China National Knowledge Infrastructure, Wanfang Database and China Biomedical Database between 1966 and 2009 was performed. RCTs comparing the use of PEGIFN vs. IFN in treating Chinese patients with hepatitis B were assessed. Of the 210 studies screened, nine RCTs included 581 patients (PEGIFN therapy 281, IFN therapy 300) were analysed. The HBeAg seroconversion rates, serum HBeAg clearance rate, serum HBV DNA clearance rate and ALT normalization rate obtained in patients treated with PEGINF were significantly higher than in patients treated with IFN at the 24th, 48th week of the treatment and the 24th, 48th week of follow-up. Safety profile was similar between patients treated with PEGIFN and IFN. Chinese patients with hepa...Continue Reading

References

Mar 1, 1995·Trends in Biotechnology·Y InadaA Matsushima
Jun 8, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N W LeungUNKNOWN Asia Hepatitis Lamivudine Study Group
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chi-Jen Chu, Anna S F Lok
Mar 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ching-Lung LaiLynn Condreay
Sep 17, 2004·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group
Jan 11, 2005·Lancet·Harry L A JanssenUNKNOWN Rotterdam Foundation for Liver Research
Jan 14, 2005·Antiviral Chemistry & Chemotherapy·Michael J Grace, David Cutler
Feb 22, 2005·Journal of Viral Hepatitis·S Schaefer
Mar 9, 2005·Vaccine·Anna KramvisGuido François
Jul 1, 2005·The New England Journal of Medicine·George K K LauUNKNOWN Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group
Aug 29, 2007·International Journal of Nanomedicine·Thea Thomas, Graham Foster

❮ Previous
Next ❯

Citations

Jan 1, 2011·ISRN Organic Chemistry·Katarzyna KielarK Michał Pietrusiewicz
Jul 11, 2014·World Journal of Gastroenterology : WJG·Gong-Ying ChenGuo-Qiang Lou
Dec 27, 2011·Expert Opinion on Emerging Drugs·Natravis Cox, Hans Tillmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
S ZhaoShuang-Suo Dang
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S ZhaoP Yang
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
D ChengS Zhao
© 2021 Meta ULC. All rights reserved